Mukka Proteins Limited has announced receipt of MarinTrust Improver Programme certification from Global Trust Certification (NSF), marking a significant milestone in the company's sustainability and responsible sourcing initiatives. The certification confirms the company's compliance with the MarinTrust Improver Programme for Responsible Supply of Marine Ingredients.

Certification Details

The certification was granted by Global Trust Certification Ltd, Ireland, and represents formal recognition of the company's adherence to responsible marine ingredient sourcing standards. The programme acceptance provides acknowledgment for sourcing marine ingredients produced using Fishery Improvement Project (FIP) raw materials.

Strategic Impact and Benefits

The MarinTrust certification delivers multiple strategic advantages for Mukka Proteins' operations and market positioning. The programme demonstrates compliance with MarinTrust Standard requirements and evidences the company's commitment to responsible sourcing and traceability of marine ingredients.

Key benefits of the certification include:

• Recognition for responsible sourcing practices using FIP raw materials
• Enhanced traceability throughout the marine ingredient supply chain
• Strengthened confidence among buyers and supply chain stakeholders
• Progress towards achieving full MarinTrust certification
• Improved supply chain integrity and product assurance

Company Operations

Mukka Proteins Limited operates as a manufacturer and exporter of steam dried fish meal, fish oil, and fish soluble paste. The company maintains ISO 22000 and ISO 9001:2015 certifications, demonstrating its commitment to quality management and food safety standards.

The company's manufacturing facility is located at Sasihithlu Road, Mukka, Mangaluru, Karnataka, while its corporate office operates from Attavara, Mangaluru. This certification reinforces the company's position in the marine ingredients sector and supports its commitment to sustainable business practices.

Regulatory Compliance

The announcement was made in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The certification aligns with the company's ongoing efforts to maintain transparency and meet regulatory requirements while advancing sustainability objectives in marine ingredient sourcing and supply chain management.

Mukka Proteins Limited has successfully completed the acquisition of the remaining minority stake in its subsidiary Ento Proteins Private Limited. The transaction, which was announced on 21st February 2026, has been completed with effect from 23rd February 2026, making Ento Proteins a wholly-owned subsidiary.

Acquisition Completion Details

The company has completed the acquisition of 1,000 equity shares of face value Rs. 100 each for a total consideration of Rs. 32,30,000. This transaction follows the Share Purchase Agreement entered into with Holocene Ecosolutions Private Limited, the existing minority shareholder.

Ento Proteins Financial Performance

Ento Proteins Private Limited, which operates as a manufacturer of insect meal and insect oil, has demonstrated consistent growth over the past three years. The subsidiary's financial metrics showcase strong performance in the alternative proteins segment.

Historical Revenue Growth

The three-year revenue trajectory of Ento Proteins demonstrates consistent growth in the alternative proteins business segment.

Strategic Investment Rationale

The acquisition aligns with Mukka Proteins' strategic investment plans to expand its alternate proteins business. As disclosed in the regulatory filing, this investment represents a strategic move to consolidate ownership and streamline operations within the subsidiary structure. The transaction was executed on an arm's length basis, with the company clarifying that while Ento Proteins is a related party as a subsidiary, the promoters' interest is limited to their directorship roles.

Regulatory Compliance

The completion disclosure has been made under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The share transfer process required no governmental or regulatory approvals and was completed through cash consideration. With this acquisition, the existing Shareholders' Agreement dated 7th September 2021 and its amendments have been rescinded and terminated in their entirety.